This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bernhardt, S. A. Search for Related Content Social Bookmarking                   What's this?

Improving Document Review Practices in Pharmaceutical Companies

University of Delaware

Document review practices in the research and development functions of many pharmaceutical companies can be frustrating and inefficient, at least in part because these practices are poorly managed. Although the literature on review practice is fairly robust, there is a disjuncture between what researchers know and how reviewers work. The author draws on his experience as a consultant and trainer to many pharmaceutical companies to outline the causes and effects of poor review practice. He offers recommendations to enhance the value and increase the efficiency of reviews.

Key Words: review • writing • pharmaceutical writing • drug development • editing • documentation

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Blythe, J. T. Grabill, and K. Riley Action Research and Wicked Environmental Problems: Exploring Appropriate Roles for Researchers in Professional Communication Journal of Business and Technical Communication, July 1, 2008; 22(3): 272 - 298. [Abstract] [PDF]